AAAAAA
Results:
1-6
|
Results: 6
Authors:
Wight, NJ
Gottesdiener, K
Garlick, NM
Atherton, CT
Novak, S
Gertz, BJ
Calder, NA
Cote, J
Wong, P
Dallob, A
Hawkey, CJ
Citation: Nj. Wight et al., Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production, GASTROENTY, 120(4), 2001, pp. 867-873
Authors:
Van Hecken, A
Schwartz, JI
Depre, M
De Lepeleire, I
Dallob, A
Tanaka, W
Wynants, K
Buntinx, A
Arnout, J
Wong, PH
Ebel, DL
Gertz, BJ
De Schepper, PJ
Citation: A. Van Hecken et al., Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers, J CLIN PHAR, 40(10), 2000, pp. 1109-1120
Authors:
Depre, M
Ehrich, E
Van Hecken, A
De Lepeleire, I
Dallob, A
Wong, P
Porras, A
Gertz, BJ
De Schepper, PJ
Citation: M. Depre et al., Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans, EUR J CL PH, 56(2), 2000, pp. 167-174
Authors:
Dallob, A
De Lepeleire, I
Van Hecken, A
Porras, A
Depre, M
Mukhopadhyay, S
Flynn, M
Wildonger, L
Gottesdiener, K
Tanaka, W
De Schepper, P
Citation: A. Dallob et al., Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration, INFLAMM RES, 48, 1999, pp. S130-S131
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
Authors:
Drake, L
Hordinsky, M
Fiedler, V
Swinehart, J
Unger, WP
Cotterill, PC
Thiboutot, DM
Lowe, N
Jacobson, C
Whiting, D
Stieglitz, S
Kraus, SJ
Griffin, EI
Weiss, D
Carrington, P
Gencheff, C
Cole, GW
Pariser, DM
Epstein, ES
Tanaka, W
Dallob, A
Vandormael, K
Geissler, L
Waldstreicher, J
Citation: L. Drake et al., The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia, J AM ACAD D, 41(4), 1999, pp. 550-554
Authors:
Ehrich, EW
Dallob, A
De Lepeleire, I
Van Hecken, A
Riendeau, D
Yuan, WY
Porras, A
Wittreich, J
Seibold, JR
De Schepper, P
Mehlisch, DR
Gertz, BJ
Citation: Ew. Ehrich et al., Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model, CLIN PHARM, 65(3), 1999, pp. 336-347
Risultati:
1-6
|